Sim SH - Search Results

1

CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer.

Sim SH, Bae CD, Kwon Y, Hwang HL, Poojan S, Hong HI, Kim K, Kang SH, Kim HS, Um TH, Park IH, Lee KS, Jung SY, Lee S, Kang HS, Lee ES, Kim MK, Hong KM, Ro J. Sim SH, et al. PLoS One. 2017 Aug 3;12(8):e0182107. doi: 10.1371/journal.pone.0182107. eCollection 2017. PLoS One. 2017. PMID: 28771517 Free PMC article.

2

A Rare Case of Phyllodes Tumor Metastasis to the Stomach Presenting as Anemia.

Choi DI, Chi HS, Lee SH, Kwon Y, Park SY, Sim SH, Park IH, Lee KS. Choi DI, et al. Among authors: sim sh. Cancer Res Treat. 2017 Jul;49(3):846-849. doi: 10.4143/crt.2016.188. Epub 2016 Sep 1. Cancer Res Treat. 2017. PMID: 27586673 Free PMC article.

3

Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01).

Park IH, Im SA, Jung KH, Sohn JH, Park YH, Lee KS, Sim SH, Park KH, Kim JH, Nam BH, Kim HJ, Kim TY, Lee KH, Kim SB, Ahn JH, Lee S, Ro J. Park IH, et al. Among authors: sim sh. Cancer Res Treat. 2019 Jan;51(1):43-52. doi: 10.4143/crt.2017.562. Epub 2018 Feb 14. Cancer Res Treat. 2019. PMID: 29458237 Free PMC article. Clinical Trial.

4

Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay.

Park SJ, Lee MH, Kong SY, Song MK, Joo J, Kwon Y, Lee EG, Han JH, Sim SH, Jung SY, Lee S, Lee KS, Park IH, Lee ES. Park SJ, et al. Among authors: sim sh. Breast Cancer Res Treat. 2018 Jul;170(1):69-76. doi: 10.1007/s10549-018-4740-z. Epub 2018 Mar 8. Breast Cancer Res Treat. 2018. PMID: 29516374

5

Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer.

Park IH, Kong SY, Kwon Y, Kim MK, Sim SH, Joo J, Lee KS. Park IH, et al. Among authors: sim sh. J Cancer. 2018 Mar 8;9(7):1145-1151. doi: 10.7150/jca.24035. eCollection 2018. J Cancer. 2018. PMID: 29675095 Free PMC article.

6

Incidence of Diabetes After Cancer Development: A Korean National Cohort Study.

Hwangbo Y, Kang D, Kang M, Kim S, Lee EK, Kim YA, Chang YJ, Choi KS, Jung SY, Woo SM, Ahn JS, Sim SH, Hong YS, Pastor-Barriuso R, Guallar E, Lee ES, Kong SY, Cho J. Hwangbo Y, et al. Among authors: sim sh. JAMA Oncol. 2018 Aug 1;4(8):1099-1105. doi: 10.1001/jamaoncol.2018.1684. JAMA Oncol. 2018. PMID: 29879271 Free PMC article.

7

Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.

Kim Y, Sim SH, Park B, Lee KS, Chae IH, Park IH, Kwon Y, Jung SY, Lee S, Ko K, Kang HS, Lee CW, Lee ES. Kim Y, et al. Among authors: sim sh. Clin Breast Cancer. 2018 Dec;18(6):459-467.e1. doi: 10.1016/j.clbc.2018.05.009. Epub 2018 Jun 7. Clin Breast Cancer. 2018. PMID: 29954674

8

Predicting Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: Combined Statistical Modeling Using Clinicopathological Factors and FDG PET/CT Texture Parameters.

Lee H, Lee DE, Park S, Kim TS, Jung SY, Lee S, Kang HS, Lee ES, Sim SH, Park IH, Lee KS, Kwon YM, Kong SY, Joo J, Jeong HJ, Kim SK. Lee H, et al. Among authors: sim sh. Clin Nucl Med. 2019 Jan;44(1):21-29. doi: 10.1097/RLU.0000000000002348. Clin Nucl Med. 2019. PMID: 30394924

9

Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health Insurance Database.

Kim YA, Cho H, Lee N, Jung SY, Sim SH, Park IH, Lee S, Lee ES, Kim HJ. Kim YA, et al. Among authors: sim sh. Cancer Med. 2018 Dec;7(12):6084-6092. doi: 10.1002/cam4.1886. Epub 2018 Nov 19. Cancer Med. 2018. PMID: 30453386 Free PMC article.

10

Integrative In Vivo Drug Testing Using Gene Expression Signature and Patient-Derived Xenografts from Treatment-Refractory HER2 Positive and Triple-Negative Subtypes of Breast Cancer.

Ryu JS, Sim SH, Park IH, Lee EG, Lee ES, Kim YH, Kwon Y, Kong SY, Lee KS. Ryu JS, et al. Among authors: sim sh. Cancers (Basel). 2019 Apr 23;11(4):574. doi: 10.3390/cancers11040574. Cancers (Basel). 2019. PMID: 31018595 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters